Sinocare Future Growth
Future criteria checks 4/6
Sinocare is forecast to grow earnings and revenue by 25.3% and 14.5% per annum respectively. EPS is expected to grow by 24.8% per annum. Return on equity is forecast to be 14.7% in 3 years.
Key information
25.3%
Earnings growth rate
24.8%
EPS growth rate
Medical Equipment earnings growth | 21.4% |
Revenue growth rate | 14.5% |
Future return on equity | 14.7% |
Analyst coverage | Low |
Last updated | 05 Apr 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 5,996 | N/A | 716 | N/A | 1 |
12/31/2025 | 5,786 | 642 | 478 | 725 | 4 |
12/31/2024 | 4,985 | 516 | 336 | 630 | 4 |
12/31/2023 | 4,262 | 402 | 195 | 483 | 4 |
9/30/2023 | 2,998 | 363 | 42 | 370 | N/A |
6/30/2023 | 2,971 | 377 | 271 | 548 | N/A |
3/31/2023 | 2,852 | 433 | 253 | 566 | N/A |
12/31/2022 | 2,814 | 431 | 163 | 474 | N/A |
9/30/2022 | 3,463 | 296 | 485 | 803 | N/A |
6/30/2022 | 3,081 | 218 | 258 | 610 | N/A |
3/31/2022 | 2,478 | 128 | 171 | 475 | N/A |
1/1/2022 | 2,361 | 108 | 76 | 480 | N/A |
9/30/2021 | 2,235 | 134 | -58 | 366 | N/A |
6/30/2021 | 2,174 | 147 | -22 | 365 | N/A |
3/31/2021 | 2,095 | 168 | 28 | 435 | N/A |
12/31/2020 | 2,015 | 187 | 229 | 505 | N/A |
9/30/2020 | 2,049 | 287 | 324 | 566 | N/A |
6/30/2020 | 1,936 | 280 | 245 | 502 | N/A |
3/31/2020 | 1,831 | 265 | 273 | 517 | N/A |
12/31/2019 | 1,778 | 251 | 101 | 523 | N/A |
9/30/2019 | 1,651 | 286 | -26 | 474 | N/A |
6/30/2019 | 1,604 | 272 | 66 | 534 | N/A |
3/31/2019 | 1,607 | 276 | -72 | 368 | N/A |
12/31/2018 | 1,551 | 310 | 77 | 319 | N/A |
9/30/2018 | 1,429 | 286 | -22 | 116 | N/A |
6/30/2018 | 1,301 | 333 | -48 | 59 | N/A |
3/31/2018 | 1,112 | 296 | 57 | 158 | N/A |
1/1/2018 | 1,033 | 258 | 145 | 244 | N/A |
9/30/2017 | 994 | 206 | 172 | 270 | N/A |
6/30/2017 | 945 | 156 | N/A | 272 | N/A |
3/31/2017 | 849 | 116 | N/A | 223 | N/A |
12/31/2016 | 796 | 115 | N/A | 203 | N/A |
9/30/2016 | 722 | 138 | N/A | 231 | N/A |
6/30/2016 | 674 | 121 | N/A | 180 | N/A |
3/31/2016 | 698 | 155 | N/A | 183 | N/A |
12/31/2015 | 646 | 144 | N/A | 122 | N/A |
9/30/2015 | 634 | 176 | N/A | 164 | N/A |
6/30/2015 | 611 | 191 | N/A | 170 | N/A |
3/31/2015 | 570 | 199 | N/A | 147 | N/A |
12/31/2014 | 545 | 197 | N/A | 153 | N/A |
9/30/2014 | 506 | 191 | N/A | 131 | N/A |
6/30/2014 | 488 | 176 | N/A | 133 | N/A |
3/31/2014 | 450 | 157 | N/A | 128 | N/A |
12/31/2013 | 449 | 165 | N/A | 114 | N/A |
9/30/2013 | 429 | 156 | N/A | 121 | N/A |
6/30/2013 | 387 | 139 | N/A | 103 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300298's forecast earnings growth (25.3% per year) is above the savings rate (2.9%).
Earnings vs Market: 300298's earnings (25.3% per year) are forecast to grow faster than the CN market (23.9% per year).
High Growth Earnings: 300298's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300298's revenue (14.5% per year) is forecast to grow faster than the CN market (14.3% per year).
High Growth Revenue: 300298's revenue (14.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300298's Return on Equity is forecast to be low in 3 years time (14.7%).